Cure Alert Yale university researcher finds possible cure for vitiligo

Tofacitinib, which is currently prescribed for rheumatoid arthritis was administered to a 53-year-old patient with prominent white spots covering her face, hands, and body and success was recorded.

  • Published:
play (The Telegraph)
24/7 Live - Subscribe to the Pulse Newsletter!

Indications are rife that the cure to skin condition, vitiligo may be on the horizon as scientists in Yale have suggested it could be cured with arthritis drug, tofacitinib.

Tofacitinib, which is currently prescribed for rheumatoid arthritis was administered to a 53-year-old patient with prominent white spots covering her face, hands, and body.

After 5 months it was found that the condition virtually disappeared, with only a few spots remaining on her body, and all had gone from her face and hands.

play (The Telegraph)

 

According to  Dr Brett King, principal investigator of the research at Yale University, the feat could be a huge step forward in the treatment of patients with this condition.

Dr King is now hoping to begin a wider clinical trial into the effectiveness of using tofacitinib or a similar medicine, ruxolitinib, for the treatment of vitiligo.

Professor David Gawkrodger, a spokesman for the British Skin Foundation Spokesperson, said the research was 'promising' but warned it was too soon for patients to be demanding Tofacitinib from their doctors.

The research was published in the journal JAMA Dermatology.

Do you ever witness news or have a story that should be featured on Pulse Nigeria?
Submit your stories, pictures and videos to us now via WhatsApp: +2349055172167, Social Media @pulsenigeria247: #PulseEyewitness & DM or Email: eyewitness@pulse.ng. More information here.